Use access key #2 to skip to page content.
$4.84 0.83 (20.70%)
10/13/2008 4:00 PM

Exelixis, Inc. (EXEL)

CAPS Rating:
*****

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

View All Commentary (EXEL)

Recs

4

Avatar TMFHelical (99.48) Submitted: 12/20/06 5:42 PM : Outperform Start Price: $9.53 EXEL Score: -21.01

I'm not one to venture into drug companies on promise. I still think the best time to invest is after it has an approval and cash coming in (when pushed, I'd say wait for the 3rd drug approval). Still, I can't help but be impressed with Exelixis. They have a nice deep pipeline and are attracting big-pharma interest as recently shown by a BMS partnership. Worth a flyer with speculative allocation $$ in my opinion. It just feels like a Vertex in the making (I just used the word 'feels' - smart investors should shudder at the combination of emotion and biotech investing).

Stick 1K into this and ignore it for 10 years.

Report this Post Replies: 0 | Reply

Featured Broker Partners